Armata Pharmaceuticals Inc (NYSEAMERICAN:ARMP), the biotechnology company, is involved in the development of pathogen-specific bacteriophage therapeutics, which are meant for targeting antibiotic-resistant and bacterial infections which are difficult to treat. The stock has been in the middle of a strong rally in recent times and it continued on Wednesday as the stock soared by 31%. …